Gynecologic Oncology News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

D Scott Cunningham MD, PhD
Site Editor, MDLinx
Markers of obesity and inflammation in postmenopausal breast cancer

Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage

Smartest Doc Challenge
MDLinx
Melanoma Clinical Pearls

MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools

MDLinx Top Read
MDLinx
Running from that pile of unread journals?

New!	>> Find out who is the Smartest Doc in Oncology!

Articles

Latest (5) Full Text Articles (316) Focus on Renal

Ranked, sorted, and summarized by MDLinx editors from the latest literature

Topics:

61 Pretreatment neutrophil-to-lymphocyte and platelet-to- lymphocyte ratios do not predict survival in patients with cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy Full Text Chinese Medical Journal, May 8, 2013 Clinical Article

62 Tubal ligation, hysterectomy, and epithelial ovarian cancer in the New England case-control study International Journal of Cancer, May 7, 2013

63 A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy Gynecologic Oncology, May 7, 2013 Clinical Article

64 Contribution of Immunohistochemical Profile in Assessing Histological Grade of Endometrial Cancer Anticancer Research, May 7, 2013 Clinical Article

65 The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients Tumor Biology, May 7, 2013 Clinical Article

66 Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102) British Journal of Cancer, May 6, 2013 Clinical Article

67 First-line paclitaxel and carboplatin in persistent/recurrent or advanced cervical cancer: a retrospective analysis of patients treated at brazilian national cancer institute International Journal of Gynecological Cancer, May 6, 2013 Clinical Article

68 Predictors of recovery of ovarian function during aromatase inhibitor therapy Annals of Oncology, May 6, 2013 Clinical Article

69 Galectin-7 Levels Predict Radiation Response in Squamous Cell Carcinoma of the Cervix Gynecologic Oncology, May 6, 2013 Clinical Article

70 Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy Radiotherapy & Oncology, May 3, 2013 Clinical Article

71 Disrupting Protein NEDDylation with MLN4924 is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer Clinical Cancer Research, May 3, 2013 Clinical Article

72 Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: A single institution experience Radiotherapy & Oncology, May 3, 2013 Clinical Article

73 Endometrial Cancer and a Family History of Cancer Gynecologic Oncology, May 3, 2013 Clinical Article

74 The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer Gynecologic Oncology, May 3, 2013 Clinical Article

75 Intensity Modulated Radiotherapy in Gynecologic Cancers: Hope, Hype or Hyperbole Gynecologic Oncology, May 3, 2013 Clinical Article

76 MicroRNAs and Recent Insights into Pediatric Ovarian Cancers Frontiers in Oncology, May 3, 2013 Clinical Article

77 Identifying serum biomarkers for ovarian cancer by screening with surface-enhanced laser desorption/ionization mass spectrometry and the artificial neural network International Journal of Gynecological Cancer, May 3, 2013 Clinical Article

78 Small Interfering RNA (siRNA)-Mediated Silencing of the M2 Subunit of Ribonucleotide Reductase: A Novel Therapeutic Strategy in Ovarian Cancer International Journal of Gynecological Cancer, May 3, 2013 Clinical Article

79 Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN 2-3)? Gynecologic Oncology, May 2, 2013

80 Non-equivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations Clinical Cancer Research, May 2, 2013 Clinical Article

50 available pages First Previous 4 5 6 7 8 9 10 11 12 13 Next Last

Clinical Pearls in Oncology

The ZORO study demonstrated that the addition of goserelin to neoadjuvant chemotherapy for early breast cancer in premenopausal women resulted in no change in post-chemotherapy rates of amenorrhea
A little over 50% of tumors in women with ER-positive, node-negative breast cancers will have a RS <18, and current data suggests that these women are UNLIKELY to receive a benefit from adjuvant chemotherapy
In patients with completely resected ER-positive DCIS when the surgical specimen also has LCIS, consider breast MRI screening in addition to mammography due to the lower sensitivity of mammograms for lobular disease

» Test your knowledge. Take the Smartest Doc challenge today!

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

1 Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions Cochrane Reviews, April 1, 2013 Review Article

2 Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere Gynecologic Oncology, April 9, 2013

3 Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group Study Gynecologic Oncology, April 18, 2013

4 Tubulin-beta-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones Cancer, April 22, 2013

5 Early detection of ovarian cancer American Journal of Obstetrics and Gynecology, April 18, 2013 Review Article

6 Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial The Lancet Oncology, March 14, 2013

7 High-grade vaginal intraepithelial neoplasia: can we be selective about who we treat? BJOG: An International Journal of Obstetrics and Gynaecology, April 4, 2013

8 Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--The Mimosa Study Journal of Clinical Oncology, March 15, 2013

9 The role of the fallopian tube in the origin of ovarian cancer American Journal of Obstetrics and Gynecology, April 18, 2013

10 Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer Gynecologic Oncology, April 26, 2013

11 Controversies of the Hormonal Conservative Treatment of Endometrial Cancer Gynecologic and Obstetric Investigation, April 1, 2013

12 An international assessment of ovarian cancer incidence and mortality Gynecologic Oncology, April 9, 2013

13 A Review of Dietary Prevention of Human Papillomavirus-Related Infection of the Cervix and Cervical Intraepithelial Neoplasia Nutrition and Cancer, April 1, 2013

14 Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts Archives of Gynecology and Obstetrics, April 10, 2013

15 Controversies of the Hormonal Conservative Treatment of Endometrial Cancer Gynecologic and Obstetric Investigation, April 12, 2013 Review Article

16 Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: Single institution experience Gynecologic Oncology, March 12, 2013

17 Fertility treatment and childhood cancer risk: A systematic meta-analysis Fertility and Sterility, April 8, 2013 Evidence Based Medicine Review Article

18 Outcome of stage IB2-IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy International Journal of Clinical Oncology, April 19, 2013

19 Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients Annals of Oncology, April 29, 2013

20 Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and amounts of extracellular microvesicles released from HPV-positive cancer cells International Journal of Cancer, April 1, 2013

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?

Gynecologic Oncology News & Articles

Articles

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

HCC risk increased in patients with AIDS

RAB25 is a prognostic marker for ovarian cancer

Most Popular Oncology Articles

Other Topics in Oncology